Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.

Name: Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.
Author: Wang, Jun-Jian

Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling. — المؤلف: Wang, Jun-Jian — Acta pharmacologica Sinica 20191223

المؤلف: Wang, Jun-Jian
النشر: Acta pharmacologica Sinica 20191223
الوصف: 1067-1075 p.
الموضوعات: ADAM Proteins؛ Animals؛ Cell Line, Tumor؛ Cell Proliferation؛ ErbB Receptors؛ Gene Expression Regulation, Neoplastic؛ Gene Knockdown Techniques؛ Histone-Lysine N-Methyltransferase